FMP
SeaStar Medical Holding Corporation
ICU
NASDAQ
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
1.29 USD
-0.015 (-1.17%)
ICU Financial Statements
Year
2024
2023
2022
2021
CF from Operating Activities
-16.01M
-10.29M
-7.79M
-5.11M
Net Income
-24.83M
-26.23M
-23.01M
-4.6M
Depreciation & Amortization
0
0
0
0
Deferred Income Taxes
0
0
0
0
Stock Based Compensation
0
1.93M
1.31M
14k
Change in Working Capital
992k
2.88M
2.55M
-680k
Accounts Receivable
0
12k
4k
0
Inventory
0
0
-4k
55k
Accounts Payable
0
2.44M
1.55M
-297k
Other Working Capital
992k
420k
1M
-438k
Other Non-Cash Items
7.83M
11.14M
11.36M
148k
CF from Investing Activities
0
0
0
-105.57M
Investments in Property, Plant & Equipment
0
0
0
0
Net Acquisitions
0
0
0
0
Investment Purchases
0
0
0
-105.57M
Sales/Maturities of Investments
0
0
0
0
Other Investing Activites
0
0
0
105.57M
CF from Financing Activities
17.65M
10.41M
7.33M
2.82M
Debt Repayment
-4.41M
3.03M
-78k
-20k
Common Stock Issued
17.44M
6.61M
10M
0
Common Stock Repurchased
0
0
0
0
Dividends Paid
0
0
0
0
Other Financing Activites
4.62M
272k
-6.15M
0
Free Cash Flow
-16.01M
-10.29M
-7.79M
-5.11M
Operating Cash Flow
-16.01M
-10.29M
-7.79M
-5.11M
Capital Expenditures
0
0
0
0
Cash at Beginning of Period
176k
47k
510k
2.81M
Cash at End of Period
1.82M
176k
47k
510k
Net Change In Cash
1.64M
129k
-463k
-2.3M
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-114.73M
-99.33M
-76.31M
-71.72M
Net Income
-24.83M
-26.23M
-23.01M
-4.6M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-139.56M
-114.73M
-99.33M
-76.31M
Other Distributions
-24.83M
-15.41M
-23.01M
-4.6M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
0
0
0
0
Annual Depreciation
0
14.01M
11.61M
4.45M
Capital Expenditure
0
0
0
0
Net PPE
0
-14.01M
-11.61M
-4.45M
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
